Graft vs Host Disease

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after allogeneic haematopoietic cell transplantation from unrelated donors. Here is the latest research.

January 10, 2021

Refined hepatic grading system in chronic graft-versus-host disease improves prognostic risk stratification of long-term outcomes

European Journal of Haematology
Igor Novitzky BassoDennis Dong Hwan Kim
January 21, 2021

Clinical development of natural killer cells expressing chimeric antigen receptors.

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
Ryan J Golden, Andrew D Fesnak
January 21, 2021

Risk Factors for Ocular Involvement in Pediatric Graft-Versus-Host Disease.

Mélanie HébertMarie-Claude Robert
January 10, 2021
Open Access

Prospective pilot trial of calcipotriene as a novel topical treatment for acute skin graft versus host disease

Bone Marrow Transplantation
Gregory WallaceSonata Jodele
January 11, 2021

Antimicrobial photodynamic therapy for recurrent herpes labialis in chronic graft-versus-host disease: a case report

Photodermatology, Photoimmunology & Photomedicine
Sandra Bastos RezendeRoberto Luiz da Silva
January 19, 2021
Open Access

Thymic activity in immune recovery after allogeneic hematopoietic stem cell transplantation in children

Central-European Journal of Immunology
MaŁgorzata Janeczko-CzarneckaMarek Ussowicz
January 13, 2021

Effect of Hepatic Impairment on the Pharmacokinetics of Itacitinib

Journal of Clinical Pharmacology
April M BarbourNaresh Punwani

Sign up to follow this feed and discover related papers.

Related Feeds

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Exosomes & Tumor Environment

Several studies have reported the role of exosomes as important mediators of angiogenesis, metastasis, and immune modulation. Exosomes also have the potential to be used as biomarkers for clinical predictions. Here is the latest research on exosomes and the tumor microenvironment.

Graft Rejection

Graft rejection occurs when the donor's grafted tissue is rejected by the recipient's immune system, destroying the transplanted tissue. Discover the latest research on graft rejection here.

Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.


Immuno-oncology (or cancer immunotherapy) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight cancer. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules. Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. Discover the latest research on immuno-oncology here.


Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Metastatic Malignancy Treatments

Treatment of metastatic cancers depends on the type of cancer and the severity of the disease. The regime often includes medications such as chemotherapy or hormone therapy, but may also include immunotherapy, radiation therapy, surgery or a combination. Discover the latest research on metastatic cancer treatments here.

Tumor Evasion of the Immune System

Tumor evasion of the immune system includes cells that operate their own growth and develop various strategies to escape from immune surveillance. Discover the latest research on tumor evasion of the immune system here.

Tumor Vaccines

Tumor vaccines offer the potential for preventing cancer in high-risk individuals, preventing disease relapse after diagnosis and initial therapy, and shifting the balance of the host-tumor interaction to mitigate the progression of advanced cancers. Discover the latest research on tumor vaccines here.

© 2021 Meta ULC. All rights reserved